FDA Inspection 1282446 — Intersect ENT, Inc.
The FDA completed an inspection of Intersect ENT, Inc. on August 7, 2025 in Menlo Park, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 7, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Menlo Park, CA (United States)